AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35503653 — intervention group
Group type: COMPARATOR
Intervention: Text messaging-based mindfulness intervention for dysregulated eating
Number of subjects: 919
Study 34182951 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (small tidal volume 8 mL/kg + PEEP 5 cmH2O)
Number of subjects: 90
Study 34182951 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (small tidal volume 8 mL/kg + PEEP 5 cmH2O + recruitment maneuvers)
Number of subjects: 90
Study 34182951 — intervention group
Group type: COMPARATOR
Intervention: Group A (conventional mechanical ventilation)
Number of subjects: 90
Study 34766822 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression
Number of subjects: 90
Study 34766822 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 90
Study 34766822 — intervention group
Group type: COMPARATOR
Intervention: Passive Monitoring
Number of subjects: 90
Study 34766822 — intervention group
Group type: EXPERIMENTAL
Intervention: UIT-related stimuli
Number of subjects: 90
Study 35074007 — intervention group
Group type: EXPERIMENTAL
Intervention: MindPower intervention (IG1)
Number of subjects: 1673
Study 35074007 — intervention group
Group type: COMPARATOR
Intervention: Control group (IG2)
Number of subjects: 1673
Study 32811272 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) - online 10 week 20 lessons video program
Number of subjects: 0
Study 32811272 — intervention group
Group type: COMPARATOR
Intervention: Control - educational videos of similar length and frequency
Number of subjects: 0
Study 36029496 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 82
Study 36029496 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 82
Study 32323940 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortexin
Number of subjects: 74
Study 32323940 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy without cortexin (Control)
Number of subjects: 74
Study 36102864 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-worst
Number of subjects: 0
Study 36102864 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranking
Number of subjects: 0
Study 36102864 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-best
Number of subjects: 0
Study 36102864 — intervention group
Group type: COMPARATOR
Intervention: All three methods
Number of subjects: 0
Study 33148247 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace Mental Health Promotion Programme (12 weeks, including reminder messages, videos, and WhatsApp texts)
Number of subjects: 70
Study 35665840 — intervention group
Group type: EXPERIMENTAL
Intervention: En-bloc TURBT
Number of subjects: 248
Study 35665840 — intervention group
Group type: EXPERIMENTAL
Intervention: DEEP scale
Number of subjects: 248
Study 33175656 — intervention group
Group type: EXPERIMENTAL
Intervention: VGX-3100
Number of subjects: 35
Study 33175656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 33276383 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 high-level prognostic metrics (MMP-9, S100A8/A9, hsCRP, GDF-15)
Number of subjects: 3575
Study 33276383 — intervention group
Group type: COMPARATOR
Intervention: 1 or 0 high-level prognostic metrics
Number of subjects: 3575
Study 33201119 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation (nutritional counseling and exercise)
Number of subjects: 118
Study 33201119 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 118
Study 34700679 — intervention group
Group type: EXPERIMENTAL
Intervention: Curative intent radiation therapy
Number of subjects: 7935
Study 34700679 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative intent radiation therapy
Number of subjects: 7935
Study 34700679 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment volume
Number of subjects: 7935
Study 34700679 — intervention group
Group type: COMPARATOR
Intervention: Palliative treatment intent
Number of subjects: 7935
Study 36160134 — intervention group
Group type: EXPERIMENTAL
Intervention: SoC plus nitazoxanide (1,000 mg b.i.d.) and atazanavir/ritonavir (300/100 mg od)
Number of subjects: 57
Study 36160134 — intervention group
Group type: COMPARATOR
Intervention: Atazanavir/ritonavir
Number of subjects: 57
Study 32326954 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive therapy for PTSD (iCT-PTSD)
Number of subjects: 217
Study 32326954 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered stress management therapy (iStress-PTSD)
Number of subjects: 217
Study 32326954 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 217
Study 32326954 — intervention group
Group type: EXPERIMENTAL
Intervention: iCT-PTSD and iStress-PTSD
Number of subjects: 217
Study 33914991 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 1284
Study 33914991 — intervention group
Group type: COMPARATOR
Intervention: ECOG-PS
Number of subjects: 1284
Study 33914991 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs)
Number of subjects: 1284
Study 33167994 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted ulcerative colitis
Number of subjects: 0
Study 33167994 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted Crohn’s disease
Number of subjects: 0
Study 34751786 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D volumetric measurements
Number of subjects: 21
Study 34751786 — intervention group
Group type: COMPARATOR
Intervention: 2D LGG RANO
Number of subjects: 21
Study 33778082 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram integrating gender, age of diagnosis, WBC at diagnosis, bone marrow leukemic blast percentage, and chromosomal abnormalities [t(8; 21), inv(16)]
Number of subjects: 440
Study 33778082 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based survival rate predictor
Number of subjects: 440
Study 32126336 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 357
Study 32126336 — intervention group
Group type: COMPARATOR
Intervention: Psychodynamic therapy
Number of subjects: 357
Study 35661212 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Intervention (MI)
Number of subjects: 43
Study 35661212 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 33560320 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (3 × 38 minutes/week)
Number of subjects: 180
Study 33560320 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Continuous Training (5 × 40 minutes/week)
Number of subjects: 180
Study 33560320 — intervention group
Group type: COMPARATOR
Intervention: Guideline Control (1-time advice on physical activity)
Number of subjects: 180
Study 35835612 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (IP)
Number of subjects: 1174
Study 35835612 — intervention group
Group type: COMPARATOR
Intervention: Intravenous chemotherapy (IV)
Number of subjects: 1174
Study 33370142 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude emotional state
Number of subjects: 379
Study 33370142 — intervention group
Group type: COMPARATOR
Intervention: Neutral emotional state
Number of subjects: 379
Study 35192031 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK) lenses
Number of subjects: 53
Study 35192031 — intervention group
Group type: COMPARATOR
Intervention: Multifocal soft contact lenses (MSCLs)
Number of subjects: 53
Study 34357857 — intervention group
Group type: EXPERIMENTAL
Intervention: Change rate of serum procalcitonin (PCT) level exceeding 50% as the switch point for weaning from mechanical ventilation.
Number of subjects: 140
Study 34357857 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group intervention based on PCT change rate.
Number of subjects: 140
Study 34357857 — intervention group
Group type: COMPARATOR
Intervention: Control group using pulmonary infection control (PIC) window.
Number of subjects: 140
Study 35577726 — intervention group
Group type: EXPERIMENTAL
Intervention: Halsted's method with spaced learning
Number of subjects: 20
Study 35577726 — intervention group
Group type: COMPARATOR
Intervention: Peyton's method with spaced learning
Number of subjects: 20
Study 34872895 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mg of Ellagic Acid (EA) per day for 2 months
Number of subjects: 44
Study 34872895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 34328473 — intervention group
Group type: EXPERIMENTAL
Intervention: PS+CA
Number of subjects: 42
Study 34328473 — intervention group
Group type: EXPERIMENTAL
Intervention: PS+MA
Number of subjects: 42
Study 34328473 — intervention group
Group type: COMPARATOR
Intervention: PM+CA
Number of subjects: 42